The Conversation (0)
Medovex scheduled its first human cases for its DenerveX System in Europe.
Medovex (NASDAQ:MDVX) scheduled its first human cases for its DenerveX System in Europe.
As quoted in the press release:
Dr. Martin Deeg, an Orthopedic Surgeon from Stuttgart, Germany will be the first surgeon to utilize the new device.
The Company previously announced that it had received its first three commercial orders for its DenerveX System on the heels of receiving CE Mark approval for the system allowing it to be marketed in Europe. The first commercial orders of the DenerveX System included both the DenerveX Kit containing the DenerveX Device and the DenerveX Pro-40 Generators for Germany, UK and Italy.
Manny Sablowski, Sr. Vice President of Sales and Marketing, stated, “We are pleased to be building atop recent momentum having established near term dates for the first human cases in the EU. The first human cases follow the recent receipt of stocking orders from our distributors EDGE Medical of Manchester England, TCB Ortho Division of Germany, and AlfaMed of Porto San Giorgio, Italy.”
Click here to read the full press release.
Source: www.marketwired.com